Tempus AI upgraded to hold from underperform; price target raised to $70 from $35
TEM•Jefferies raised its rating on Tempus AI to hold from underperform and increased its price target to $70 from $35.
Related News
Axsome Therapeutics target price raised to $249 from $247 by Morgan Stanley
AXSM•
Caledonia Mining publishes update to financial calendar
CMCL•
Global markets were already fragile. Big AI bets could break them
SPY•
Robinhood Markets: BofA Global Research cuts price objective to $151 from $156
HOOD•
Nasdaq price objective raised to $135 from $133
NDAQ•